Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
Theoharis C. Theoharides
BioFactors (2020) Vol. 46, Iss. 3, pp. 306-308
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings
International Journal of Infectious Diseases (2020) Vol. 100, pp. 327-332
Open Access | Times Cited: 280
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.
The Neuroscientist (2020) Vol. 26, Iss. 5-6, pp. 402-414
Open Access | Times Cited: 267
Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review
Charis M. Galanakis, Turki M.S. Aldawoud, Myrto Rizou, et al.
Foods (2020) Vol. 9, Iss. 11, pp. 1701-1701
Open Access | Times Cited: 218
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 162
Mast cell activation symptoms are prevalent in Long-COVID
Leonard B. Weinstock, Jill Brook, Arthur S. Walters, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 217-226
Open Access | Times Cited: 134
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 127
Pathophysiology of Post-COVID syndromes: a new perspective
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 93
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 52
Tackling the cytokine storm in COVID-19, challenges and hopes
Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, et al.
Life Sciences (2020) Vol. 257, pp. 118054-118054
Open Access | Times Cited: 106
Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis
Jarbas da Silva Motta, Anna Flavia Ribeiro dos Santos Miggiolaro, Seigo Nagashima, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 97
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 96
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
Wenhao Niu, Feng Wu, Wenyue Cao, et al.
Bioscience Reports (2020) Vol. 41, Iss. 1
Open Access | Times Cited: 95
Research Progress of the Antiviral Bioactivities of Natural Flavonoids
Lin Wang, Junke Song, Ailin Liu, et al.
Natural Products and Bioprospecting (2020) Vol. 10, Iss. 5, pp. 271-283
Open Access | Times Cited: 89
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 84
Potential association of mast cells with coronavirus disease 2019
Theoharis C. Theoharides
Annals of Allergy Asthma & Immunology (2020) Vol. 126, Iss. 3, pp. 217-218
Open Access | Times Cited: 79
Implications of SARS‐CoV‐2 infection for neurogastroenterology
Giovanni Marasco, Marco Vincenzo Lenti, Cesare Cremon, et al.
Neurogastroenterology & Motility (2021) Vol. 33, Iss. 3
Open Access | Times Cited: 72
Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
Paraskevi Detopoulou, Constantinos A. Demopoulos, Smaragdi Antonopoulou
Nutrients (2021) Vol. 13, Iss. 2, pp. 462-462
Open Access | Times Cited: 64
Paving Luteolin Therapeutic Potentialities and Agro‐Food‐Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits
Yasaman Taheri, Javad Sharifi‐Rad, Gizem Antika, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 63
Basophils and Mast Cells in COVID-19 Pathogenesis
Giuseppe Murdaca, Mario Di Gioacchino, Mónica Greco, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2754-2754
Open Access | Times Cited: 61
Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles
Mariela Jiménez, Daniel Cervantes‐García, Laura Elena Córdova-Dávalos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57
Mast cell-mediated immune regulation in health and disease
Kottarappat N. Dileepan, Vineesh V. Raveendran, Rishi Sharma, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 35
COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 28
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top